Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-10-20

Clinical Trial Update: Preoperative Nivolumab Plus Bevacizumab Combined With Chemotherapy Before Surgery in Patients With pMMR/MSS Colorectal Cancer Liver Metastases [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating preoperative nivolumab plus bevacizumab with chemotherapy before surgery in patients with mismatch repair proficient/microsatell…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bevacizumab (bevacizumab)
  • nivolumab (nivolumab)

Snippet

Sponsor: Shanghai Changzheng Hospital | Conditions: Colorectal Cancer Liver Metastases | Phase 2 | Status: UNKNOWN